Package

- Janssen Pharmaceutica NV
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a perspective view of another embodiment of a new design of a package shown with a drug delivery device disposed therein;

FIG. 2 is a perspective view of the package of FIG. 1 shown with a lid removed;

FIG. 3 is a top view of the package of FIG. 1;

FIG. 4 is a top view of the package of FIG. 1 with the drug delivery device removed;

FIG. 5 is a bottom view of the package of FIG. 1;

FIG. 6 is a left view of the package of FIG. 1;

FIG. 7 is a right view of the package of FIG. 1;

FIG. 8 is a front view of the package of FIG. 1;

FIG. 9 is a back view of the package of FIG. 1; and,

FIG. 10 is an exploded view of the package of FIG. 1.

In the drawings, the broken lines are for the purpose of illustrating portions of the package that form no part of the claimed design.

Claims

The ornamental design for a package, as shown and described.

Referenced Cited
U.S. Patent Documents
D430015 August 29, 2000 Himbert
6228324 May 8, 2001 Hasegawa et al.
D549094 August 21, 2007 Oner et al.
D569721 May 27, 2008 Gedanke
D623935 September 21, 2010 Kim et al.
D697398 January 14, 2014 Guevara-ludt
D743249 November 17, 2015 Wintmolders et al.
D750502 March 1, 2016 Kirchmayr et al.
D754547 April 26, 2016 Psimadas et al.
D758180 June 7, 2016 Wintmolders et al.
9422094 August 23, 2016 Niiro et al.
D765520 September 6, 2016 Gunder et al.
D767985 October 4, 2016 Schouten
D774903 December 27, 2016 Joergensen et al.
D775945 January 10, 2017 Dichiara et al.
D780599 March 7, 2017 Tilahun et al.
D785451 May 2, 2017 Biery
D788936 June 6, 2017 Schill
D790987 July 4, 2017 Damon et al.
D790988 July 4, 2017 Vasiliadis et al.
D804962 December 12, 2017 Fox et al.
D808823 January 30, 2018 Greene et al.
D810556 February 20, 2018 Holm
D814314 April 3, 2018 Mecker et al.
D814918 April 10, 2018 Bos
D818815 May 29, 2018 Psimadas et al.
10053272 August 21, 2018 Doherty et al.
D840800 February 19, 2019 Farrell
D841460 February 26, 2019 Toledo
D842092 March 5, 2019 Toledo
D847253 April 30, 2019 Chang
D847624 May 7, 2019 Farrell
D850289 June 4, 2019 Mccay et al.
D853249 July 9, 2019 Mckendree
D854408 July 23, 2019 Farrell
D855450 August 6, 2019 Klein et al.
D856793 August 20, 2019 Debnath et al.
D860435 September 17, 2019 Wang
D870550 December 24, 2019 Klein et al.
D871205 December 31, 2019 Farrell
D873131 January 21, 2020 Watanabe
D877613 March 10, 2020 Mcfaul et al.
10577165 March 3, 2020 Sadowski et al.
D882415 April 28, 2020 Duarte De Castro et al.
D887283 June 16, 2020 Sennett et al.
D887700 June 23, 2020 Folger et al.
D890330 July 14, 2020 Wang
D892636 August 11, 2020 Troudt et al.
D898588 October 13, 2020 An et al.
D906102 December 29, 2020 Cook et al.
D909890 February 9, 2021 Bryzek et al.
D915904 April 13, 2021 Duarte De Castro et al.
D918710 May 11, 2021 Hampton et al.
D920573 May 25, 2021 Scudieri
D934069 October 26, 2021 Cook
D938831 December 21, 2021 Picken et al.
D939139 December 21, 2021 Waters
11230419 January 25, 2022 Tilahun
D945847 March 15, 2022 Chen
D949018 April 19, 2022 Gysel et al.
D953886 June 7, 2022 Collier et al.
D957245 July 12, 2022 Müller
D958645 July 26, 2022 Debnath et al.
D959052 July 26, 2022 Gerhards et al.
D961376 August 23, 2022 Cook
D964171 September 20, 2022 Gysel
D985384 May 9, 2023 Cannamela
20180085515 March 29, 2018 Mide
20230037529 February 9, 2023 Cannamela
Foreign Patent Documents
113226 February 1992 AU
316236 September 2007 AU
316320 September 2007 AU
201713235 June 2017 AU
2015001855 December 2014 CL
2017001388 January 2016 CL
2020001658 December 2019 CL
2020001659 December 2019 CL
2020001661 December 2019 CL
2020001660 October 2020 CL
09046884 May 2011 CO
0002438940001 January 2005 EM
20200007409 December 2019 NC
D139069 February 2011 TW
D171654 November 2015 TW
Other references
  • Dispositivo de medicamento Spravato (Janssen Pharmaceutica NV) Mar. 6, 2019, www.scmp., 2 pages.
Patent History
Patent number: D1015139
Type: Grant
Filed: Mar 9, 2023
Date of Patent: Feb 20, 2024
Assignee: Janssen Pharmaceutica NV (Beerse)
Inventors: Michael Cannamela (Atlantic Highland, NJ), Emma Hubert (San Jose, CA)
Primary Examiner: Rhea Shields
Application Number: 29/872,262
Classifications
Current U.S. Class: D9/416